510(k) · Cleared
ClearedReach Hip Component
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet, Inc. · LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
Cleared on Aug 24, 1998 as substantially equivalent to K933942 (Depuy, Inc., 1994) and 4 other predicates after a 48-day review. Its family tree reaches back 1 generation to 1994. 209 later devices descend from it.
- Decided
- Aug 24, 1998
- Review
- 48 days
- Class
- Class II
- Product code
- LPH
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 1 generation to K921225 (1994). 5 ancestors in all. 209 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK921225 Integral Total Hip SystemBiomet, Inc. · 1994
- This deviceK982367 Reach Hip ComponentBiomet, Inc. · 1998
- Descendant · cites it directly · 208 of its ownK030055 Mallory/Head Total Hip System; HA Mallory/Head Total Hip System…Biomet, Inc. · 2003 · Recalled
- Descendant · 2 generations on · 160 of its ownK043537 Taperloc 12/14 Taper Femoral ComponentsBiomet, Inc. · 2005
- Descendant · 2 generations on · 138 of its ownK050124 Porous Coated Acetabular ComponentsBiomet, Inc. · 2005 · Recalled
- Descendant · 3 generations on · 137 of its ownK070369 Regenerx Ringloc + Modular Acetabular ShellsBiomet, Inc. · 2007 · Recalled
- Descendant · 4 generations on · 65 of its ownK093235 Ringloc + Hybrid Acetabular SystemBiomet, Inc. · 2010 · Recalled
Showing 5 of 209 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 209 · See all- K030055Mallory/Head Total Hip System; HA Mallory/Head Total Hip System; BI-Metric Femoral…Biomet, Inc. · 2003 · cites it directly208descendants
- K043537Taperloc 12/14 Taper Femoral ComponentsBiomet, Inc. · 2005 · 2 generations on160descendants
- K050124Porous Coated Acetabular ComponentsBiomet, Inc. · 2005 · 2 generations on138descendants
- K070369Regenerx Ringloc + Modular Acetabular ShellsBiomet, Inc. · 2007 · 3 generations on137descendants
- K093235Ringloc + Hybrid Acetabular SystemBiomet, Inc. · 2010 · 4 generations on65descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K921225 | Integral Total Hip System | Biomet, Inc. | 1994 | — |
| 0 (this device) | K982367 | Reach Hip Component | Biomet, Inc. | 1998 | — |
| +1 | K030055 | Mallory/Head Total Hip System; HA Mallory/Head Total Hip System; BI-Metric… | Biomet, Inc. | 2003 | 3 |
| +2 | K043537 | Taperloc 12/14 Taper Femoral Components | Biomet, Inc. | 2005 | — |
| +2 | K050124 | Porous Coated Acetabular Components | Biomet, Inc. | 2005 | 1 |
| +3 | K070369 | Regenerx Ringloc + Modular Acetabular Shells | Biomet, Inc. | 2007 | 19 |
| +4 | K093235 | Ringloc + Hybrid Acetabular System | Biomet, Inc. | 2010 | 30 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 1 | 0 |
| 2005 | 5 | 0 |
| 2006 | 2 | 0 |
| 2007 | 3 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 4 | 0 |
| 2012 | 15 | 0 |
| 2013 | 10 | 0 |
| 2014 | 16 | 0 |
| 2015 | 11 | 0 |
| 2016 | 9 | 0 |
| 2017 | 12 | 0 |
| 2018 | 7 | 0 |
| 2019 | 21 | 0 |
| 2020 | 8 | 0 |
| 2021 | 8 | 0 |
| 2022 | 12 | 0 |
| 2023 | 14 | 0 |
| 2024 | 13 | 0 |
| 2025 | 16 | 0 |
| 2026 | 17 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LPH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LPH device
- #1 K233498 Stryker Orthopaedics Hip Systems Labeling Updatescore 24.3 · 20 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K933942 | Solution Bowed Femoral Hip ProtsthesisSummary page 2…ly equivalent to most femoral devices on the market in overall design and intended function. Predicate devices include: The Solution System® Depuy, Warsaw, IN 510(k) # K933942, K941942, K953703 Integral® Total Hip system, Biomet, Inc., Warsaw, IN 510(K) #K921255 Foundation® Porous Hip Stem, Encore Orthop… | 1994 |
| * | K941942 | Solution HipSummary page 2…lent to most femoral devices on the market in overall design and intended function. Predicate devices include: The Solution System® Depuy, Warsaw, IN 510(k) # K933942, K941942, K953703 Integral® Total Hip system, Biomet, Inc., Warsaw, IN 510(K) #K921255 Foundation® Porous Hip Stem, Encore Orthopedics, Au… | 1994 |
| * | K953703 | Depuy Vision Solution Hip ProsthesisSummary page 2…ost femoral devices on the market in overall design and intended function. Predicate devices include: The Solution System® Depuy, Warsaw, IN 510(k) # K933942, K941942, K953703 Integral® Total Hip system, Biomet, Inc., Warsaw, IN 510(K) #K921255 Foundation® Porous Hip Stem, Encore Orthopedics, Austin TX 5… | 1996 |
| * | K921225 | Integral Total Hip System Our OCR of the scanned summary read K921255, FDA’s number for Philips BV26 Mobile C-Arm Stand (Philips Medical Systems, Inc.). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “Integral® Total Hip system”. | 1994 |
| * | K973302 | Foundation Porous Hip StemSummary page 2…510(k) # K933942, K941942, K953703 Integral® Total Hip system, Biomet, Inc., Warsaw, IN 510(K) #K921255 Foundation® Porous Hip Stem, Encore Orthopedics, Austin TX 510(K) 973302 00061. C DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corpora… | 1997 |
What descends from it? (209)
See all 2092 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All LPH devicesLPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LPH
12in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LPH
153in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LPH
4in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LPH
6,163in 2025
MAUDE reports naming product code LPH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 116 | 16 | 509 |
| 2008 | 10 | 86 | 1 | 706 |
| 2009 | 3 | 112 | 2 | 1,156 |
| 2010 | 15 | 100 | 22 | 2,007 |
| 2011 | 16 | 110 | 26 | 3,320 |
| 2012 | 25 | 76 | 30 | 3,785 |
| 2013 | 11 | 135 | 9 | 5,002 |
| 2014 | 20 | 129 | 3 | 5,163 |
| 2015 | 18 | 111 | 1 | 5,830 |
| 2016 | 10 | 150 | 8 | 4,900 |
| 2017 | 12 | 121 | 14 | 5,312 |
| 2018 | 9 | 145 | 2 | 5,954 |
| 2019 | 22 | 164 | 8 | 7,130 |
| 2020 | 7 | 164 | 6 | 5,429 |
| 2021 | 8 | 410 | 4 | 5,978 |
| 2022 | 14 | 247 | 2 | 5,223 |
| 2023 | 10 | 111 | 2 | 5,345 |
| 2024 | 6 | 92 | 1 | 5,626 |
| 2025 | 12 | 153 | 4 | 6,163 |
| 2026 | 8 | 256 | 2 | — |
What is it indicated for?
The indications for use of the Reach Femoral Component are:
a.) non-inflammatory degenerative disease
b.) osteoarthritis
c.) avascular necrosis
d.) rheumatoid arthritis
e.) revisions of hip replacement components
f.) treatment of non-union, femoral neck and trochanteric fractures of the proximal femur with head involvement.
The Reach stem is intended for press-fit application and for single use implantation.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K982367 · printed Nov 4, 2026
Cite this page
510(k) Report. “K982367: Reach Hip Component.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K982367
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026